Intracavernosal Injection of Botulinum Toxin Type A (50 and 100 Unit) in the Treatment of Erectile Dysfunction
Comparative Study Between Intracavernosal Injection of Botulinum Toxin Type A (50 and 100 Unit) Efficacy and Durability in the Treatment of Vascular Erectile Dysfunction
Sponsor: Benha University
A PHASE2 clinical study on Botulinum Toxin and Erectile Dysfunction, this trial is completed. The trial is conducted by Benha University and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2019 — Jan 2021 [monthly]
Completed PHASE2
-
Mar 2019 — Dec 2019 [monthly]
Completed PHASE2
Status: Enrolling By Invitation → Completed
▶ Show 4 earlier versions
-
Feb 2019 — Mar 2019 [monthly]
Enrolling By Invitation PHASE2
-
Sep 2018 — Feb 2019 [monthly]
Enrolling By Invitation PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Enrolling By Invitation PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE2
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Benha University
- Cairo University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.